ONEXTON 37.5 mg/g (Clindamycin Phosphate and Benzoyl Peroxide GEL) 37.5 mg/g

ONEXTON 37.5 mg/g is a topical gel combining clindamycin phosphate and benzoyl peroxide for acne treatment. This dual-action formula targets acne-causing bacteria and reduces inflammation. Ideal for those seeking effective acne solutions.

Strength

37.5 mg/g

Pack Size

3.5 g in 1 TUBE (0187-3050-35)

Manufacturer / TM Owner

Bausch Health US, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ONEXTON 37.5 mg/g is primarily used for the treatment of acne vulgaris. The combination of clindamycin phosphate, an antibiotic, and benzoyl peroxide, an exfoliant, works to reduce acne lesions and prevent new breakouts. This gel is applied topically to affected areas, making it a common choice for those looking to manage acne symptoms.

Side Effects

When used as directed, ONEXTON 37.5 mg/g may help reduce the number of acne lesions and improve the overall appearance of the skin. Some users may experience temporary redness, dryness, or peeling at the application site. These effects are generally mild and should subside with continued use.

Precautions & Warnings

Before using ONEXTON 37.5 mg/g, it is important to follow the instructions provided by your healthcare professional. Avoid contact with eyes, lips, and mucous membranes. If irritation occurs, discontinue use and consult a healthcare provider. Keep out of reach of children and store at room temperature.

Avoid Interactions

ONEXTON 37.5 mg/g may interact with other topical products, particularly those containing alcohol or other drying agents. It is advisable to avoid using other acne treatments simultaneously unless directed by a healthcare provider. Always inform your healthcare professional about all medications and skincare products you are using.

Frequently Asked Questions

ONEXTON 37.5 mg/g is used for the treatment of acne vulgaris. It combines clindamycin phosphate and benzoyl peroxide to reduce acne lesions and prevent new breakouts.

Apply a thin layer of ONEXTON 37.5 mg/g gel to the affected areas of the skin once or twice daily, or as directed by your healthcare provider.

Common side effects may include temporary redness, dryness, or peeling at the application site. These effects are usually mild and should subside with continued use.

It is advisable to avoid using other acne treatments simultaneously unless directed by a healthcare provider, as ONEXTON 37.5 mg/g may interact with other topical products.

ONEXTON 37.5 mg/g is generally suitable for most skin types, but individual reactions may vary. If irritation occurs, discontinue use and consult a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.